| 37526549 | Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). | Neuro Oncol | 2023 |
| 36369715 | [Formula: see text] The neuropsychological profile of children with Diffuse Intrinsic Pontine Glioma (DIPG) before and after radiation therapy: A prospective longitudinal study. | Child Neuropsychology | 2023 |
| 36124689 | Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. | Neuro Oncol | 2023 |
| 37126770 | Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group. | J Clin Oncol | 2023 |
| 34999836 | Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. | Neuro Oncol | 2022 |
| 35901835 | Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2022 |
| 35439702 | Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2. | Journal of Clinical Virology | 2022 |
| 35484114 | Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors. | Cell Death Dis | 2022 |
| 35790014 | Single-dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in cats. | Journal of Veterinary Pharmacology and Therapeutics | 2022 |
| 35536420 | Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0. | European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
| 36509072 | Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 34174070 | Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors. | Neuro Oncol | 2022 |
| 35049364 | Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute. | Journal of Adolescent and Young Adult Oncology | 2022 |
| 35130560 | GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. | Nature | 2022 |
| 34551090 | Corrigendum to: Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors. | Neuro Oncol | 2021 |
| 34168987 | Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors. | Front Oncol | 2021 |
| 34055371 | Adolescent and young adult neuro-oncology: a comprehensive review. | Neuro-Oncology Practice | 2021 |
| 33664971 | Reirradiation practices for children with diffuse intrinsic pontine glioma. | Neuro-Oncology Practice | 2021 |
| 33025730 | Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial. | Pediatr Blood Cancer | 2021 |
| 34898668 | Pharmacokinetics of the disialoganglioside, G, a circulating tumor biomarker for neuroblastoma, in nonhuman primates. | Journal of Circulating Biomarkers | 2021 |
| 32502457 | Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 32309806 | Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models. | Neuro-Oncology Advances | 2020 |
| 31894347 | Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma. | Cancer Chemotherapy and Pharmacology | 2020 |
| 32306101 | Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib. | Cancer Chemotherapy and Pharmacology | 2020 |
| 32162805 | Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs. | Oncologist | 2020 |
| 33046181 | Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques () Based on the Pharmacokinetics of Intrathecally Administered Inulin. | | 2020 |
| 33040274 | A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas. | J Neurooncol | 2020 |
| 33036139 | Pharmacokinetic Principles and Their Application to Central Nervous System Tumors. | Pharmaceutics | 2020 |
| 32506137 | MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. | Neuro Oncol | 2020 |
| 32502459 | Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 32502458 | Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 30464022 | Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013. | Cancer Epidemiology Biomarkers and Prevention | 2019 |
| 31748226 | Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. | Sci Transl Med | 2019 |
| 29769209 | Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials. | Clinical Cancer Research | 2018 |
| 29016845 | Pediatric low-grade gliomas: next biologically driven steps. | Neuro Oncol | 2018 |
| 28985362 | Combatting the opioid epidemic: Baltimore's experience and lessons learned. | Journal of Public Health | 2018 |
| 28449033 | Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. | Neuro Oncol | 2018 |
| 30018882 | Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma. | Frontiers in Oncology | 2018 |
| 30544335 | Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma. | Journal of Neurosurgery: Pediatrics | 2018 |
| 30051085 | Making Naloxone Rescue Part of Basic Life Support Training for Medical Students. | AEM Educ Train | 2018 |
| 29954750 | Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. | Blood | 2018 |
| 29998396 | Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. | Journal of Neuro-Oncology | 2018 |
| 30322880 | Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. | Clin Cancer Res | 2018 |
| 29226552 | Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome. | American Journal of Medical Genetics, Part A | 2018 |
| 29712574 | Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. | Journal for ImmunoTherapy of Cancer | 2018 |
| 29746225 | Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. | J Clin Oncol | 2018 |
| 29329453 | Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee". | Neuro Oncol | 2018 |
| 29788429 | Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. | Neuro Oncol | 2018 |
| 28290002 | Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model. | Journal of Neuro-Oncology | 2017 |
| 28824876 | Gliomatosis Cerebri: Current Understanding and Controversies. | Frontiers in Oncology | 2017 |